Wells Fargo & Company Emergent Bio Solutions Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,347 shares of EBS stock, worth $79,046. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,347

Previous 20,012 58.29%

Holding current value

$79,046

Previous $167,000 52.69%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$7.72 - $11.97 $90,053 - $139,630	-11,665 Reduced 58.29%	8,347 $79,000
Q3 2024 Nov 13, 2024	BUY	$5.72 - $14.77 $94,248 - $243,365	16,477 Added 466.11%	20,012 $167,000
Q2 2024 Aug 13, 2024	SELL	$1.86 - $6.98 $34,914 - $131,021	-18,771 Reduced 84.15%	3,535 $24,000
Q1 2024 May 10, 2024	BUY	$1.5 - $3.41 $3,759 - $8,545	2,506 Added 12.66%	22,306 $56,000
Q4 2023 Feb 09, 2024	BUY	$1.82 - $3.16 $4,422 - $7,678	2,430 Added 13.99%	19,800 $47,000
Q3 2023 Nov 13, 2023	SELL	$3.17 - $7.91 $349,540 - $872,196	-110,265 Reduced 86.39%	17,370 $59,000
Q2 2023 Aug 15, 2023	BUY	$7.35 - $13.21 $273,868 - $492,217	37,261 Added 41.23%	127,635 $938,000
Q1 2023 May 12, 2023	BUY	$7.79 - $16.29 $556,478 - $1.16 Million	71,435 Added 377.18%	90,374 $936,000
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $90,772 - $177,005	8,252 Added 77.22%	18,939 $223,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $3.31 Million - $5.9 Million	-164,923 Reduced 93.91%	10,687 $224,000
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $3.11 Million - $4.95 Million	-113,540 Reduced 39.27%	175,610 $5.45 Million
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $973,359 - $1.39 Million	-26,682 Reduced 8.45%	289,150 $11.9 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $3.35 Million - $5.57 Million	-101,319 Reduced 24.29%	315,832 $13.7 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $6.31 Million - $8.33 Million	126,093 Added 43.32%	417,151 $20.9 Million
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $9.65 Million - $13.7 Million	-170,494 Reduced 36.94%	291,058 $18.3 Million
Q1 2021 May 13, 2021	BUY	$86.23 - $125.19 $1.57 Million - $2.29 Million	18,255 Added 4.12%	461,552 $42.9 Million
Q4 2020 Feb 09, 2021	SELL	$79.17 - $111.47 $13 Million - $18.3 Million	-164,414 Reduced 27.05%	443,297 $39.7 Million
Q3 2020 Nov 05, 2020	BUY	$81.91 - $134.94 $11.5 Million - $19 Million	140,558 Added 30.09%	607,711 $62.8 Million
Q2 2020 Aug 13, 2020	SELL	$54.33 - $89.52 $112,680 - $185,664	-2,074 Reduced 0.44%	467,153 $36.9 Million
Q1 2020 May 14, 2020	BUY	$49.34 - $68.76 $23.2 Million - $32.3 Million	469,227 New	469,227 $27.2 Million

Others Institutions Holding EBS

# of Institutions

159

Shares Held

34.4M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $472M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Emergent Bio Solutions Inc. Transaction History